# Sonoma Biotherapeutics, Inc. — Form D

Sonoma Biotherapeutics, Inc. of SOUTH SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2021-08-11. The offering totals $265.0M, of which $265.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2021-08-11
- Form: D
- Accession: 0001877861-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $265.0M
- Amount sold: $265.0M
- Remaining: $7
- Investors: 40
- Date of first sale: 2021-07-26
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-409599

## Issuer

- Name: Sonoma Biotherapeutics, Inc.
- CIK: 0001877861
- Entity type: Corporation
- Jurisdiction: CALIFORNIA
- Incorporated: 2019
- Address: 400 E. JAMIE CT., SUITE 202, SOUTH SAN FRANCISCO, CA, 94080
- Phone: (415) 992-6245

## Officers, directors & promoters (8)

| Name | Role | Location |
| --- | --- | --- |
| Jeffrey Bluestone | Director | South San Francisco, CA |
| Toni Hoover | Director | South San Francisco, CA |
| Richard Klausner | Director | South San Francisco, CA |
| Terry Rosen | Director | Hillsborough, CA |
| Maggie Wilderotter | Director | Palo Alto, CA |
| Fan Yu | Director | Grand Cayman, E9 |
| Jeffrey Bluestone | Executive Officer | South San Francisco, CA |
| Jeffrey Bluestone | Promoter | South San Francisco, CA |

## More

- [CIK 1877861 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1877861&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001877861-21-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.